Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge. / Eliasen, Astrid; Callesen, Michael Thude; Dalhoff, Kim Peder; Rechnitzer, Catherine; Schmiegelow, Kjeld; Schrøder, Henrik; Tuckuviene, Ruta; Holst, Helle.
I: Ugeskrift for Laeger, Bind 180, Nr. 35, V11170851, 2018.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge
AU - Eliasen, Astrid
AU - Callesen, Michael Thude
AU - Dalhoff, Kim Peder
AU - Rechnitzer, Catherine
AU - Schmiegelow, Kjeld
AU - Schrøder, Henrik
AU - Tuckuviene, Ruta
AU - Holst, Helle
PY - 2018
Y1 - 2018
N2 - Nausea and vomiting are burdensome side effects of chemotherapy. Vomiting is observed in up to 60% of treated children. An appropriate and effective antiemetic regimen has the potential to eradicate or reduce the symptoms. Differences in local guidelines characterise the antiemetic treatment across the four Danish paediatric oncology departments because the overall knowledge of the most effective antiemetics is incomplete. There is an unmet need for research, which can promote evidence-based guidelines. The impact of host genome polymorphisms should be included in the research.
AB - Nausea and vomiting are burdensome side effects of chemotherapy. Vomiting is observed in up to 60% of treated children. An appropriate and effective antiemetic regimen has the potential to eradicate or reduce the symptoms. Differences in local guidelines characterise the antiemetic treatment across the four Danish paediatric oncology departments because the overall knowledge of the most effective antiemetics is incomplete. There is an unmet need for research, which can promote evidence-based guidelines. The impact of host genome polymorphisms should be included in the research.
M3 - Tidsskriftartikel
C2 - 30152323
VL - 180
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 35
M1 - V11170851
ER -
ID: 219534279